Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : ACMI - Accumed Inc. -- Ignore unavailable to you. Want to Upgrade?

To: CARYTRE who wrote (1196)	1/18/1998 1:45:00 PM
From: Cisco	Read Replies (1) \| Respond to of 1894

Cary, Speaking of relative value, did you know that back in early 1996 when this stock was selling for around $7.00/share and AccuMed had much less to offer Peter Gombrich made the following statement: Number one, the company is very under-valued at this time, because it merged with a public shell, so it has a very low baseline. Number two, we are playing in a major market area that is nearly $3 billion untapped. And, three, we have a demonstrable product that is being sold and that has been tested by major laboratories who have expressed tremendous interest. (Wall Street Corporate Reporter, Vol.1, Issue 1 April 29-May5, 1996.) Cisco